|
|
|
|
Impact of Direct-Acting Antiviral Treatment for
Hepatitis C on Cardiovascular Diseases and Extrahepatic Cancers
|
|
|
Laurent Lam, MD
Pierre Louis Institute of Epidemiology and Public Health (IPLESP), Sorbonne University, Paris, FRANCE
Laurent Lam, MD; Helene Fontaine, MD; Nathanael Lapidus, MD, PhD; Celine Dorival, PhD; Jonathan Bellet, BS; Dominique Larrey, MD, PhD; Pierre Nahon, MD, PhD; Alpha Diallo, MD; Carole Cagnot, PhD; Clovis Lusivika-Nzinga, PhD; François Teoule, PhD; Gilles Hejblum, PhD ; Marc Bourliere, MD; Stanislas Pol, MD, PhD; Fabrice Carrat, MD, PhD; for the ANRS/AFEF Hepather study group
|
|
|
|
|
|
|